Fidelity Investments’s Larimar Therapeutics LRMR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$40K Buy
13,830
+12,518
+954% +$36.2K ﹤0.01% 3997
2025
Q1
$2.82K Sell
1,312
-42,891
-97% -$92.2K ﹤0.01% 4829
2024
Q4
$171K Sell
44,203
-482,547
-92% -$1.87M ﹤0.01% 3327
2024
Q3
$3.45M Buy
526,750
+1,029
+0.2% +$6.74K ﹤0.01% 2237
2024
Q2
$3.81M Buy
525,721
+525,005
+73,325% +$3.81M ﹤0.01% 2159
2024
Q1
$5.43K Buy
716
+140
+24% +$1.06K ﹤0.01% 4473
2023
Q4
$2.62K Buy
576
+179
+45% +$815 ﹤0.01% 4594
2023
Q3
$1.57K Buy
397
+185
+87% +$731 ﹤0.01% 4589
2023
Q2
$664 Buy
+212
New +$664 ﹤0.01% 4769
2019
Q3
Sell
-71,421
Closed -$1.02M 4054
2019
Q2
$1.02M Sell
71,421
-56,041
-44% -$800K ﹤0.01% 2449
2019
Q1
$4.19M Sell
127,462
-66,109
-34% -$2.17M ﹤0.01% 2126
2018
Q4
$11.5M Sell
193,571
-15,045
-7% -$894K ﹤0.01% 1757
2018
Q3
$29.3M Sell
208,616
-130,427
-38% -$18.3M ﹤0.01% 1528
2018
Q2
$41.6M Hold
339,043
﹤0.01% 1370
2018
Q1
$30.3M Hold
339,043
﹤0.01% 1526
2017
Q4
$18.8M Sell
339,043
-63
-0% -$3.49K ﹤0.01% 1745
2017
Q3
$14.3M Hold
339,106
﹤0.01% 1815
2017
Q2
$14.3M Buy
339,106
+63
+0% +$2.65K ﹤0.01% 1810
2017
Q1
$19M Sell
339,043
-42
-0% -$2.35K ﹤0.01% 1711
2016
Q4
$12.9M Hold
339,085
﹤0.01% 1874
2016
Q3
$13.5M Buy
339,085
+42
+0% +$1.67K ﹤0.01% 1869
2016
Q2
$24.4M Hold
339,043
﹤0.01% 1580
2016
Q1
$27.2M Hold
339,043
﹤0.01% 1523
2015
Q4
$25.6M Hold
339,043
﹤0.01% 1568
2015
Q3
$130M Buy
339,043
+12,355
+4% +$4.74M 0.02% 841
2015
Q2
$136M Hold
326,688
0.02% 887
2015
Q1
$155M Buy
326,688
+42,851
+15% +$20.4M 0.02% 818
2014
Q4
$105M Buy
283,837
+11,253
+4% +$4.16M 0.01% 982
2014
Q3
$64.3M Buy
+272,584
New +$64.3M 0.01% 1181